AIMT
Aimmune Therapeutics, Inc.
GM, Europe Susan E. Barrowcliffe sold $300K of Aimmune Therapeutics, Inc.
Sold$300,000
$20.00Price
15,000Shares
−100%Stake
What AIMT did after the filing
Prices for AIMT after this filing aren't in yet.
Traded Tue, Nov 8. Filed Thu, Nov 10, 11:05 AM ET, during the session. Not investment advice.